Skip to content
Cold-chain shipping · Ships from Canada · Research use only
Neural

Dihexa in Canada

Dihexa is a small lab-made molecule built from angiotensin IV, a piece of a blood pressure hormone. Washington State University developed it and tested it in lab models of memory loss. Three of its main papers were retracted, or pulled, in 2025. One outside lab study still stands. It has had no human trials and is not approved anywhere.

Dihexa peptide 5mg vial, Pro Peptide
$55.77CAD per vial

Pack prices and discount codes don't combine. You always get the bigger saving.

Strength5mg
1

Sold for laboratory research use only. Not for human or veterinary use. 19+.

Molar mass
504.7g/mol
Hormone fragment it was designed from
Ang IV
Pathway it was built to switch on
HGF/c-Met
Registered human trials
0
Approved as a drug
Nowhere

What is Dihexa?

The plain-language version, first.

Most compounds on this shelf have a thin file. This one has something different and worse.

It had a substantial file, and then part of that file was withdrawn.

Three foundational papers retracted in 2025. Not disputed. Retracted.

Dihexa is a derivative of angiotensin IV, engineered for the two things small molecules always get engineered for, which is surviving the body long enough to matter and getting where it is going.

The chemistry is real and it is not in question. What is in question is a chunk of the evidence that made anybody care.

One independent lab study survives the retractions. Zero human trials exist. That is the whole standing file.

What is dihexa, and what happened to its evidence base?

What researchers watch it do.

Here's an uncomfortable thing about mechanism sections generally.

They read the same whether the underlying work held up or not. The prose does not know.

So read this one knowing that some of the papers it would normally rest on are no longer there.

The proposed target involves hepatocyte growth factor signalling and its receptor. That pathway is real, well studied, and has nothing to do with this compound's problems.

What a retraction removes is not the pathway. It removes the specific evidence that this molecule engages it the way it was claimed to.

Here's the honest part, and it is blunter than we would normally be.

When foundational papers come out of the literature, the correct response is to treat the compound as less established than it was last year, not to keep quoting the papers.

What does the research say about Dihexa?

What the studies found, and where they stand.

This is the shortest research summary in the catalogue and it is short on purpose.

2025: three foundational papers retracted. That is the single most important fact about this compound and it belongs first, not buried under mechanism.

One independent lab study survives. Zero human trials. Zero.

A lot of what is written about dihexa online predates the retractions and has not been revisited, which means the internet's confidence level is running about a year behind the literature.

We stock it, and we are not going to describe an evidence base that partly no longer exists.

A compound is only as good as the papers still standing behind it, and three of these are not.

Dihexa, research grade, sold for laboratory use only.

What did the lab find in our Dihexa?

The lab's numbers for the lot on the shelf.

99.38%HPLC purity
Lot 2288-218
LaboratoryJanoshik Analytical
TestedMarch 2026
MethodHPLC + mass spectrometry
Size5 mg
Reported resultsas reported by the laboratory
HPLC purity
99.38%
Identity
Confirmed
Measured content
label 5 mg4.94 mg

See the lab results page

What's in a vial of Dihexa?

The chemistry, exactly as released.

Handling
FormatLyophilized powder
Storage−20 °C, desiccated
ReconstitutionBacteriostatic water
Work out the drawPeptide calculatorLab resultsLot 2288-218

Who studies Dihexa?

Who tends to order this one, and why.

  1. 1

    Researchers auditing a nootropic literature

    Dihexa is the cleanest available case study in how a compound's reputation can outlive its citations. The gap between forum consensus and the current record is unusually wide here.

  2. 2

    Groups working on angiotensin IV chemistry

    The AT4 area is small, and dihexa is its most modified derivative. The hexanoyl and aminohexanoic amide caps are a textbook stability and permeability solve.

  3. 3

    Labs modelling PI3K/AKT in cognition

    The surviving 2021 APP/PS1 result points at PI3K/AKT rather than HGF, which makes dihexa an odd but live tool compound for that pathway.

  4. 4

    Anyone comparing dihexa to fosgonimeton

    They are different molecules from the same lineage. Athira's failed LIFT-AD trial tested fosgonimeton, and attributing that trial to dihexa is a common and consequential error.

Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.

Where did Dihexa come from?

How it got here.

Angiotensin IV showing up in memory research was already an odd turn. It's a fragment off a blood pressure hormone. Nobody drew that one on a whiteboard on purpose.

Joseph Harding's lab at Washington State University chased it anyway, and dihexa came out of that chase. The compound got spun into a startup called M3 Biotechnology, which renamed itself Athira Pharma in 2019 and went public with a lot of attention on it.

Then 2021 happened. Leen Kawas, Athira's CEO and a former PhD student in Harding's lab, was placed on leave over allegations that images in published work had been altered. A special committee at the company found she had altered images in her dissertation and in at least four papers. She left the company. In 2025 the three foundational mechanism papers were retracted.

The company moved on to fosgonimeton, a different compound, and that failed its Phase 2/3 trial in Alzheimer's.

We're not telling you this to scare you off. We're telling you because if you buy dihexa and read about it afterward, you're going to find this story anyway, and you should get it from the people selling it rather than from a forum thread.

  1. 1

    A blood pressure fragment with a side gig

    Angiotensin IV is part of the renin-angiotensin system. Its effects on memory in lab models were not what anyone was looking for when that system was being mapped.

  2. 2

    From a Pullman lab to a public company

    Developed in Joseph Harding's lab at Washington State University, spun out into M3 Biotechnology, renamed Athira Pharma in 2019.

  3. 3

    2021 to 2025

    Athira's CEO, a former PhD student in the same lab, was placed on leave in 2021 over image alteration allegations and left after a company committee made findings against her. The three foundational mechanism papers were retracted in 2025.

How do I buy Dihexa in Canada?

What ships, how fast, and the paperwork.

Research use only. Sold for laboratory research use only, not for human or veterinary consumption. Health Canada's advisory of 9 April 2026 states that peptides are generally regulated as prescription drugs in Canada, and that "For Research Use Only" labelling does not make these products legal. Dihexa is not named in that advisory, which is not the same as being permitted.

Check which molecule a claim belongs to. Dihexa, PNB-0408 and ATH-1001 are the same compound. Fosgonimeton is not. A lot of published commentary blends the two, and the human trial data belongs entirely to fosgonimeton.

Sport testing. Dihexa is not named on the WADA Prohibited List. It is caught by S0, non-approved substances, and arguably by S2.3, which explicitly names hepatocyte growth factor.

What else do people ask?

5 answers, none of them dodges.

Were dihexa's studies really retracted?

Three of them, in 2025. They're the foundational papers from the Washington State lab describing the hepatocyte growth factor and c-Met mechanism (PMIDs 40312092, 40312093, 40312094). One is the 2014 JPET paper that most dihexa write-ups paraphrase. A retraction doesn't prove the conclusions were wrong, but it does mean those papers and every number in them are no longer citable evidence.

Is there any dihexa research left standing?

Yes, and it's worth knowing. An independent group with no Washington State connection reported that dihexa restored spatial learning in an Alzheimer's lab model through PI3K/AKT signalling (Sun, 2021, Brain Sciences, PMID 34827486). That's the strongest surviving result. There's also a negative one. PNB-0408 failed to protect against motor or cognitive deficits in a lab model of Huntington's disease (Wells, 2024).

Has dihexa been tested in humans?

No. ClinicalTrials.gov returns zero registered studies for dihexa. This is the single most important fact on the page and it gets buried constantly. Athira Pharma did run human trials, but on fosgonimeton, a different molecule from the same lineage, and its Phase 2/3 LIFT-AD trial in mild to moderate Alzheimer's failed. That trial is not dihexa evidence.

What about the claim that dihexa is far more potent than BDNF?

We went looking for a source and couldn't find one outside the retracted literature. Same with the widely repeated three-fold increase in spine number, which traces back to a retracted paper. If a page quotes either figure at you without naming where it came from, that's the reason. We're not printing numbers we can't stand behind.

What is dihexa chemically?

N-hexanoyl-Tyr-Ile-(6)-aminohexanoic amide. Formula C27H44N4O5, molecular weight 504.7, CAS 1401708-83-5. It's derived from angiotensin IV, a fragment of the renin-angiotensin system, with a hexanoyl cap on one end and an aminohexanoic amide on the other to improve stability and brain penetration. It also appears in the literature as PNB-0408 and ATH-1001.

What pairs well with Dihexa?

What researchers stack alongside it.

Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as Dihexa, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

NeuralSemax Peptide
$39.77
CAD

A tiny lab-made protein built in Moscow from one chopped-off piece of a stress hormone, and sold in Russian pharmacies as nose drops. Scientists study it on stroke and on BDNF, which is basically plant food for your nerve cells.

1
In stock · ships same-day with ice pack
NeuralP21 Peptide
$54.77
CAD

A short lab-made peptide based on a growth factor your nerves use, wearing a stiff little carbon cage that helps it get into the brain. Think of a backstage pass stapled to a protein, and so far it's only been studied on memory loss in lab animals.

1

Supplies for the lab

SuppliesBacteriostatic Water

The water every freeze-dried vial needs, and the one item everybody forgets. Sterile water with a preservative, so one vial lasts more than one draw.

1
In stock · ships same-day with ice pack

What else is in Neural?

Other compounds in the same research category.

See all 8 in Neural →

Ready to order Dihexa?

One last look before you decide.

Freeze-dried, lab results on the page, ships cold

You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, Dihexa is right here.

For research use only

Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.

Page last updated November 12, 2026. Reviewed by the Pro Peptide team.

What do people search for with Dihexa?

Related searches.